CUMBERLAND PHARMACEUTICALS I's ticker is CPIX and the CUSIP is 230770109. A total of 31 filers reported holding CUMBERLAND PHARMACEUTICALS I in Q4 2017. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $27,000 | -3.6% | 10,000 | 0.0% | 0.00% | – |
| Q2 2021 | $28,000 | -6.7% | 10,000 | 0.0% | 0.00% | – |
| Q1 2021 | $30,000 | 0.0% | 10,000 | 0.0% | 0.00% | – |
| Q4 2020 | $30,000 | -6.2% | 10,000 | 0.0% | 0.00% | – |
| Q3 2020 | $32,000 | -3.0% | 10,000 | 0.0% | 0.00% | – |
| Q2 2020 | $33,000 | -8.3% | 10,000 | 0.0% | 0.00% | – |
| Q1 2020 | $36,000 | -30.8% | 10,000 | 0.0% | 0.00% | – |
| Q4 2019 | $52,000 | -11.9% | 10,000 | 0.0% | 0.00% | -100.0% |
| Q3 2019 | $59,000 | -7.8% | 10,000 | 0.0% | 0.00% | 0.0% |
| Q2 2019 | $64,000 | +10.3% | 10,000 | 0.0% | 0.00% | 0.0% |
| Q1 2019 | $58,000 | -3.3% | 10,000 | 0.0% | 0.00% | 0.0% |
| Q4 2018 | $60,000 | +5.3% | 10,000 | 0.0% | 0.00% | 0.0% |
| Q3 2018 | $57,000 | -6.6% | 10,000 | 0.0% | 0.00% | 0.0% |
| Q2 2018 | $61,000 | -9.0% | 10,000 | 0.0% | 0.00% | 0.0% |
| Q1 2018 | $67,000 | -9.5% | 10,000 | 0.0% | 0.00% | 0.0% |
| Q4 2017 | $74,000 | +4.2% | 10,000 | 0.0% | 0.00% | 0.0% |
| Q3 2017 | $71,000 | +1.4% | 10,000 | 0.0% | 0.00% | 0.0% |
| Q2 2017 | $70,000 | +1.4% | 10,000 | 0.0% | 0.00% | 0.0% |
| Q1 2017 | $69,000 | +25.5% | 10,000 | 0.0% | 0.00% | 0.0% |
| Q4 2016 | $55,000 | +10.0% | 10,000 | 0.0% | 0.00% | 0.0% |
| Q3 2016 | $50,000 | +11.1% | 10,000 | 0.0% | 0.00% | 0.0% |
| Q2 2016 | $45,000 | 0.0% | 10,000 | 0.0% | 0.00% | 0.0% |
| Q1 2016 | $45,000 | -15.1% | 10,000 | 0.0% | 0.00% | 0.0% |
| Q4 2015 | $53,000 | -8.6% | 10,000 | 0.0% | 0.00% | -50.0% |
| Q3 2015 | $58,000 | -19.4% | 10,000 | 0.0% | 0.00% | 0.0% |
| Q2 2015 | $72,000 | +7.5% | 10,000 | 0.0% | 0.00% | 0.0% |
| Q1 2015 | $67,000 | +11.7% | 10,000 | 0.0% | 0.00% | 0.0% |
| Q4 2014 | $60,000 | +22.4% | 10,000 | 0.0% | 0.00% | +100.0% |
| Q3 2014 | $49,000 | +8.9% | 10,000 | 0.0% | 0.00% | -50.0% |
| Q2 2014 | $45,000 | – | 10,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 286,655 | $541,778 | 0.01% |
| Renaissance Technologies | 555,763 | $1,050 | 0.00% |
| Oakworth Capital, Inc. | 3,052 | $5,768 | 0.00% |
| ACADIAN ASSET MANAGEMENT LLC | 188,164 | $354 | 0.00% |
| MORGAN STANLEY | 11,274 | $21,308 | 0.00% |
| BlackRock Inc. | 110,990 | $209,771 | 0.00% |
| Bank of New York Mellon Corp | 75,268 | $142,256 | 0.00% |
| Citadel Advisors | 32,400 | $61,236 | 0.00% |
| Citadel Advisors | 6,400 | $12,096 | 0.00% |
| Citadel Advisors | 5,933 | $11,213 | 0.00% |